Don't forget our competitors in the rnai field, Dicerna, Regulus, Artubus, Alnylam, are years ahead of us, having been through clinical trials, but with mixed results.
- Forums
- ASX - By Stock
- BLT
- Ann: Appendix 4C - quarterly
Ann: Appendix 4C - quarterly, page-41
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)